Please enable JavaScript to continue using this application.

Compare $CRVO vs $HRGN | Chartloom

Compare

$CRVO vs $HRGN

CervoMed Inc · Harvard Apparatus Regenerative Technology Inc

CRVO

CervoMed Inc

HRGN

Harvard Apparatus Regenerative Technology Inc

Compare $CRVO vs $HRGN

Comparing CervoMed Inc and Harvard Apparatus Regenerative Technology Inc

CRVOCervoMed Inc

HRGNHarvard Apparatus Regenerative Technology Inc

CRVOCervoMed Inc

Market cap

$44M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-95.7%

YTD performance

-58.7%

52W performance

-63.8%

FCF yield

-64.2%

HRGNHarvard Apparatus Regenerative Technology Inc

Market cap

$40M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

44.6%

YTD performance

16.2%

52W performance

-15.8%

FCF yield

-9.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CRVO

HRGN

Detailed metrics comparison

CRVO

CervoMed Inc

HRGN

Harvard Apparatus Regenerative Technology Inc

Market Cap

CRVO$44M

HRGN$40M

Enterprise Value

CRVO$21M

HRGN$41M

Price

CRVO$3.22

HRGN$2.30

P/E Ratio

CRVON/A

HRGNN/A

P/S Ratio

CRVO131.50x

HRGN41.18x

EV/Sales

CRVO63.70x

HRGN41.33x

EV/EBITDA

CRVO0.00x

HRGN0.00x

P/B Ratio

CRVO1.99x

HRGN507.11x

P/FCF Ratio

CRVON/A

HRGNN/A

EV/FCF

CRVO-0.75x

HRGN-11.16x

PEG Ratio

CRVON/A

HRGNN/A

Forward P/E (NTM)

CRVON/A

HRGNN/A

Forward P/S (NTM)

CRVON/A

HRGNN/A

Revenue (TTM)

CRVO$331K

HRGN$982K

Revenue Growth (YoY)

CRVO-95.7%

HRGN44.6%

Forward Rev Growth

CRVO2153.6%

HRGN0.0%

Gross Margin (TTM)

CRVO0.0%

HRGN7.5%

Operating Margin (TTM)

CRVO0.0%

HRGN0.0%

EBITDA Margin (TTM)

CRVO-9406.8%

HRGN-682.9%

Net Margin (TTM)

CRVO-9160.8%

HRGN-680.5%

FCF Margin (TTM)

CRVO-8444.8%

HRGN-370.2%

Net Income (TTM)

CRVO$-30M

HRGN$-7M

FCF (TTM)

CRVO$-28M

HRGN$-4M

EPS (TTM)

CRVO-$2.96

HRGN-$0.38

ROE (TTM)

CRVO-15602.0%

HRGN-78637.0%

ROA (TTM)

CRVO-12834.0%

HRGN-30701.0%

ROIC (TTM)

CRVO-15602.0%

HRGN-77233.0%

Cash

CRVO$22M

HRGN$351K

Debt

CRVO$0

HRGN$500K

Net Cash/Debt

CRVO$22M

HRGN$-149K

Current Ratio (TTM)

CRVO8.57x

HRGN0.26x

Quick Ratio (TTM)

CRVO8.36x

HRGN0.12x

Debt/Equity (TTM)

CRVO0.00x

HRGN0.00x

Debt/Assets (TTM)

CRVO0.0%

HRGN0.0%

Interest Coverage (TTM)

CRVON/A

HRGNN/A

Net Debt/EBITDA (TTM)

CRVO0.00x

HRGN0.00x

Beta

CRVO-0.69

HRGN-0.50

52W Performance

CRVO-63.8%

HRGN-15.8%

YTD Performance

CRVO-58.7%

HRGN16.2%

% from 52W High

CRVO-67.8%

HRGN-21.2%

% from 52W Low

CRVO51.2%

HRGN145.8%

Asset Turnover (TTM)

CRVO0.07x

HRGN0.45x

FCF Yield (TTM)

CRVO-64.2%

HRGN-9.0%

Earnings Yield (TTM)

CRVO-69.7%

HRGN-16.5%

Dividend Yield (TTM)

CRVON/A

HRGNN/A

Rule of 40

CRVO-8,540.5

HRGN-325.5

EV/GP/RG

CRVON/A

HRGNN/A

Ticker research

View CRVO research View HRGN research

Metric	CRVO CervoMed Inc	HRGN Harvard Apparatus Regenerative Technology Inc
Market & Valuation
Market Cap	$44M	$40M
Enterprise Value	$21M	$41M
Price	$3.22	$2.30
P/E Ratio	N/A	N/A
P/S Ratio	131.50x	41.18x
EV/Sales	63.70x	41.33x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.99x	507.11x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.75x	-11.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$331K	$982K
Revenue Growth (YoY)	-95.7%	44.6%
Forward Rev Growth	2153.6%	0.0%
Profitability
Gross Margin (TTM)	0.0%	7.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-9406.8%	-682.9%
Net Margin (TTM)	-9160.8%	-680.5%
FCF Margin (TTM)	-8444.8%	-370.2%
Net Income (TTM)	$-30M	$-7M
FCF (TTM)	$-28M	$-4M
EPS (TTM)	-$2.96	-$0.38
ROE (TTM)	-15602.0%	-78637.0%
ROA (TTM)	-12834.0%	-30701.0%
ROIC (TTM)	-15602.0%	-77233.0%
Financial Health
Cash	$22M	$351K
Debt	$0	$500K
Net Cash/Debt	$22M	$-149K
Current Ratio (TTM)	8.57x	0.26x
Quick Ratio (TTM)	8.36x	0.12x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.69	-0.50
52W Performance	-63.8%	-15.8%
YTD Performance	-58.7%	16.2%
% from 52W High	-67.8%	-21.2%
% from 52W Low	51.2%	145.8%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.45x
FCF Yield (TTM)	-64.2%	-9.0%
Earnings Yield (TTM)	-69.7%	-16.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8,540.5	-325.5
EV/GP/RG	N/A	N/A
Ticker research	View CRVO research	View HRGN research

Valuation

P/S Ratio

HRGN

41.18x

CRVO

131.50x

EV/FCF

HRGN

-11.16x

CRVO

-0.75x

Growth & revenue

Revenue Growth TTM

HRGN

44.6%

CRVO

-95.7%

Forward Revenue Growth

CRVO

2153.6%

HRGN

0.0%

Profitability & performance

Gross Margin

HRGN

7.5%

CRVO

0.0%

ROE

CRVO

-15602.0%

HRGN

-78637.0%

FCF Yield %

HRGN

-9.0%

CRVO

-64.2%

52-Week Performance

HRGN

-15.8%

CRVO

-63.8%

Detailed metrics comparison

CRVO

CervoMed Inc

HRGN

Harvard Apparatus Regenerative Technology Inc

Market Cap

CRVO$44M

HRGN$40M

Enterprise Value

CRVO$21M

HRGN$41M

Price

CRVO$3.22

HRGN$2.30

P/E Ratio

CRVON/A

HRGNN/A

P/S Ratio

CRVO131.50x

HRGN41.18x

EV/Sales

CRVO63.70x

HRGN41.33x

EV/EBITDA

CRVO0.00x

HRGN0.00x

P/B Ratio

CRVO1.99x

HRGN507.11x

P/FCF Ratio

CRVON/A

HRGNN/A

EV/FCF

CRVO-0.75x

HRGN-11.16x

PEG Ratio

CRVON/A

HRGNN/A

Forward P/E (NTM)

CRVON/A

HRGNN/A

Forward P/S (NTM)

CRVON/A

HRGNN/A

Revenue (TTM)

CRVO$331K

HRGN$982K

Revenue Growth (YoY)

CRVO-95.7%

HRGN44.6%

Forward Rev Growth

CRVO2153.6%

HRGN0.0%

Gross Margin (TTM)

CRVO0.0%

HRGN7.5%

Operating Margin (TTM)

CRVO0.0%

HRGN0.0%

EBITDA Margin (TTM)

CRVO-9406.8%

HRGN-682.9%

Net Margin (TTM)

CRVO-9160.8%

HRGN-680.5%

FCF Margin (TTM)

CRVO-8444.8%

HRGN-370.2%

Net Income (TTM)

CRVO$-30M

HRGN$-7M

FCF (TTM)

CRVO$-28M

HRGN$-4M

EPS (TTM)

CRVO-$2.96

HRGN-$0.38

ROE (TTM)

CRVO-15602.0%

HRGN-78637.0%

ROA (TTM)

CRVO-12834.0%

HRGN-30701.0%

ROIC (TTM)

CRVO-15602.0%

HRGN-77233.0%

Cash

CRVO$22M

HRGN$351K

Debt

CRVO$0

HRGN$500K

Net Cash/Debt

CRVO$22M

HRGN$-149K

Current Ratio (TTM)

CRVO8.57x

HRGN0.26x

Quick Ratio (TTM)

CRVO8.36x

HRGN0.12x

Debt/Equity (TTM)

CRVO0.00x

HRGN0.00x

Debt/Assets (TTM)

CRVO0.0%

HRGN0.0%

Interest Coverage (TTM)

CRVON/A

HRGNN/A

Net Debt/EBITDA (TTM)

CRVO0.00x

HRGN0.00x

Beta

CRVO-0.69

HRGN-0.50

52W Performance

CRVO-63.8%

HRGN-15.8%

YTD Performance

CRVO-58.7%

HRGN16.2%

% from 52W High

CRVO-67.8%

HRGN-21.2%

% from 52W Low

CRVO51.2%

HRGN145.8%

Asset Turnover (TTM)

CRVO0.07x

HRGN0.45x

FCF Yield (TTM)

CRVO-64.2%

HRGN-9.0%

Earnings Yield (TTM)

CRVO-69.7%

HRGN-16.5%

Dividend Yield (TTM)

CRVON/A

HRGNN/A

Rule of 40

CRVO-8,540.5

HRGN-325.5

EV/GP/RG

CRVON/A

HRGNN/A

Ticker research

View CRVO research View HRGN research

Metric	CRVO CervoMed Inc	HRGN Harvard Apparatus Regenerative Technology Inc
Market & Valuation
Market Cap	$44M	$40M
Enterprise Value	$21M	$41M
Price	$3.22	$2.30
P/E Ratio	N/A	N/A
P/S Ratio	131.50x	41.18x
EV/Sales	63.70x	41.33x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.99x	507.11x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.75x	-11.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$331K	$982K
Revenue Growth (YoY)	-95.7%	44.6%
Forward Rev Growth	2153.6%	0.0%
Profitability
Gross Margin (TTM)	0.0%	7.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-9406.8%	-682.9%
Net Margin (TTM)	-9160.8%	-680.5%
FCF Margin (TTM)	-8444.8%	-370.2%
Net Income (TTM)	$-30M	$-7M
FCF (TTM)	$-28M	$-4M
EPS (TTM)	-$2.96	-$0.38
ROE (TTM)	-15602.0%	-78637.0%
ROA (TTM)	-12834.0%	-30701.0%
ROIC (TTM)	-15602.0%	-77233.0%
Financial Health
Cash	$22M	$351K
Debt	$0	$500K
Net Cash/Debt	$22M	$-149K
Current Ratio (TTM)	8.57x	0.26x
Quick Ratio (TTM)	8.36x	0.12x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.69	-0.50
52W Performance	-63.8%	-15.8%
YTD Performance	-58.7%	16.2%
% from 52W High	-67.8%	-21.2%
% from 52W Low	51.2%	145.8%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.45x
FCF Yield (TTM)	-64.2%	-9.0%
Earnings Yield (TTM)	-69.7%	-16.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8,540.5	-325.5
EV/GP/RG	N/A	N/A
Ticker research	View CRVO research	View HRGN research